IN VITRO STUDIES ON CYANIDIN PROTECTION AGAINST DOXORUBICIN CARDIOMYOCYTE CYTOTOXICITY AND ANTICANCER ACTIVITY
Notice bibliographique
Résumé
Mitochondrial reactive oxygen species (ROS) are recognized for their role in several health related problems when produced at excessively high concentrations. Due to their potent antioxidant activity and potential mitochondriotropic behavior, the anthocyanidins may have the potential to lower mitochondrial ROS levels. Nevertheless, the effect of anthocyanidins remains overlooked due to their presumed low stability and bioavailability. In addition, this instability has lead to a general belief that the phenolic degradation products, protocatechuic acid (PCA) and phloroglucinaldehye (PGA), exert the bioactivity rather than the parent compound. \nIn this work, doxorubicin-induced cytotoxicity in differentiated H9c2 cardiomyocytes was initially established as a model in which the mitochondrial antioxidant activity of the selected flavonoids would be examined. First, we delineated the mechanisms by which doxorubicin affected H9c2 cell survival and mitochondrial function. The results showed that the early effects of doxorubicin on mitochondrial superoxide generation led to a delayed effect on cell survival. Using this model, we then revealed the protective ability of cyanidin against doxorubicin-induced cytological damage, showing protection to mitochondria. While cyanidin co-incubation with doxorubicin did not show protection when cell survival was assessed after 24 h, it gave delayed protection after a further 24 h drug-free period. Using the delayed protection model, we also showed that cyanidin had greater bioactivity over other flavonoids tested (quercetin, catechin and cyanidin-3-glucoside (C3G)). The protection by cyanidin also exceeded that of its degradation products (PCA and PGA), suggesting that the parent compound has additional bioactivity. The cytoprotective ability of the flavonoids was related to their ability to lower mitochondrial superoxide at early time points, with cyanidin being the most effective. Experiments on doxorubicin cytotoxicity to HepG2 (liver cancer) and K562 (erythroleukemia) cells showed no protective effect with cyanidin. These results suggest cyanidin protects cardiomyocytes but does not interfere with the cytotoxic activity of doxorubicin in the cancer cell lines. \nInvestigations on the degradation of cyanidin in physiological media, UV-vis, HPLC and MS analytical techniques provided evidence that cyanidin does not degrade immediately to PCA and PGA. Instead, intermediate compounds (hemiketal and chalcone) survived for sufficient periods to exert putative bioactivity. Studies on the influence of different media on the degradation of cyanidin showed that the stability in human serum was significantly higher (t½ 43.2 min at room temperature, 22 ¬± 1°C) compared to phosphate buffered saline and Dulbecco’s Modified Eagle’s Medium with and without 10% fetal bovine serum (t½ 10.2-32.6 min). \nIn conclusion, using differentiated H9c2 cells, our results show an ability of cyanidin to survive long enough in cell culture media, and presumably intracellularly, to exert cytoprotection against doxorubicin which exceeded that of other flavonoids (quercetin, catechin, C3G) and its degradation products (PCA and PGA). The results present cyanidin as a possible antioxidant choice to use in clinical practice to protect the heart from the mitochondrial toxicity of doxorubicin and warrants investigation into this possible therapeutic application.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,001 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».